Halloran M E, Struchiner C J, Longini I M
Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Am J Epidemiol. 1997 Nov 15;146(10):789-803. doi: 10.1093/oxfordjournals.aje.a009196.
Vaccine efficacy and effectiveness (VE) are generally measured as 1 minus some measure of relative risk (RR) in the vaccinated group compared with the unvaccinated group (VE = 1 - RR). In designing a study to evaluate vaccination, the type of effect and the question of interest determine the appropriate choice of comparison population and parameter. Possible questions of interest include that of the biologic effect of vaccination on susceptibility, on infectiousness, or on progression to disease in individuals. The indirect effects, total effects, and overall public health benefits of widespread vaccination of individuals within the context of a vaccination program might also be of primary concern. The change in behavior induced by belief in the protective effects of vaccination might influence the estimates of these effects or might itself be of interest. In this paper, the authors present a framework of study designs that relates the scientific question of interest to the choice of comparison groups, the unit of observation, the level of information available for analysis, and the parameter of effect.
疫苗效力和效果(VE)通常通过接种疫苗组与未接种疫苗组相比的相对风险(RR)的某种度量的1减去该度量来衡量(VE = 1 - RR)。在设计评估疫苗接种的研究时,效应类型和感兴趣的问题决定了比较人群和参数的适当选择。可能感兴趣的问题包括疫苗接种对个体易感性、传染性或疾病进展的生物学效应。在疫苗接种计划的背景下,对个体进行广泛疫苗接种的间接效应、总体效应和整体公共卫生益处也可能是主要关注点。因相信疫苗接种的保护作用而引起的行为变化可能会影响这些效应的估计,或者其本身也可能是感兴趣的。在本文中,作者提出了一个研究设计框架,该框架将感兴趣的科学问题与比较组的选择、观察单位、可用于分析的信息水平以及效应参数联系起来。